Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 401–500 of 1,004
Hançer, N. J., Qiu, W., Cherella, C., Li, Y., Copps, K. D., & White, M. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554162 · Cited by 107
“Because a limited number of phospho-specific antibodies were generated in early studies, the phosphorylation of a few Ser/Thr residues (Ser302Irs1, Ser-307Irs1, Ser-318Irs1, Ser-612Irs1, and Ser-632Irs1) has been interrogated in many different contexts, whereas many others have never been examined (6).”
InfluentialMetabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral
Sandoval, V., Sanz‐Lamora, H., Arias, G., Marrero, P. F., Haro, D., & Relat, J. (2020) · Nutrients · doi:10.3390/nu12082393 · Cited by 132
“The activation of the mTOR/S6K phosphorylates and desensitizes the insulin receptor substrate 1 (IRS1) [157].”
BackgroundA liaison between mTOR signaling, ribosome biogenesis and cancer
Gentilella, A., Kozma, S. C., & Thomas, G. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.02.005 · Cited by 137
Self-citationHouten, S. M., & Auwerx, J. H. (2004) · Cell · doi:10.1016/j.cell.2004.09.016 · Cited by 134
“This muscle energy nutrient-sensing signaling pathway (Um et al., 2004), 2 Institut Clinique de la Souris 1 Rue Laurent Friesand cyclin T1/cyclin-dependent kinase 9 (Sano et al., 2004).”
BackgroundSelf-citationTherapeutic targeting of the mTOR ‐signalling pathway in cancer: benefits and limitations
Moschetta, M., Reale, A., Marasco, C., Vacca, A., & Carratù, M. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12749 · Cited by 128
“Although the activation of mTORC1 may be PI3K independent in some tumours, both signalling networks remain subject to complex crosstalk and feedback interactions in normal and tumour cells: the phosphorylated P70S6K protein downstream to mTORC1 exerts a negative feedback on insulin and insulin-like growth factor 1 (IG…”
BackgroundSignaling mechanisms underlying the insulin-sensitizing effects of adiponectin
Cheng, K. K. Y., Lam, K. S. L., Wang, B., & Xu, A. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.06.006 · Cited by 129
Liu, X., Niu, Y., Yuan, H., Huang, J. Y., & Fu, L. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.015 · Cited by 125
“On the other hand, hyperactivation of mTORC1 has been implicated in decreased insulin signal transduction [8,27], making the decreased AMPK activity and over-activated mTORC1 signaling a potential mechanism responsible for decreased glucose uptake in autophagy-inhibited cells.”
BackgroundDali-Youcef, N., Mataki, C., Coste, A., Messaddeq, N., Giroud, S., Blanc, S., Koehl, C., Champy, M.-F., Chambon, P., Fajas, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611568104 · Cited by 117
Self-citationOpposite Effects of Tor1 and Tor2 on Nitrogen Starvation Responses in Fission Yeast
Weisman, R., Roitburg, I., Schonbrun, M., Harari-Steinfeld, R., & Kupiec, M. (2007) · Genetics · doi:10.1534/genetics.106.064170 · Cited by 129
Selman, C., Kerrison, N. D., Cooray, A., Piper, M. D. W., Lingard, S. J., Barton, R. H., Schuster, E. F., Blanc, E., Gems, D., Nicholson, J. K., et al. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00084.2006 · Cited by 116
“Interestingly, global deletion of S6K1 in mice causes mild growth retardation, enhanced insulin sensitivity, and reduced fat mass (60), all features shared by CR rodents and to an extent by Ames dwarf mice (17).”
BackgroundChopra, I., Li, H. F., Wang, H., & Webster, K. A. (2012) · Diabetologia · doi:10.1007/s00125-011-2407-y · Cited by 116
“Activated S6K then contributes to the negative feedback regulation of the insulin signal by phosphorylating IRS-1-Ser636 and -639, thereby inhibiting PI3K [15, 16, 36].”
Yuskaitis, C. J., Jones, B. M., Wolfson, R. L., Super, C. E., Dhamne, S. C., Rotenberg, A., Sabatini, D. M., Sahin, M., & Poduri, A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.12.010 · Cited by 113
Drosophila Melted Modulates FOXO and TOR Activity
Teleman, A. A., Chen, Y., & Cohen, S. M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.07.004 · Cited by 127
Chang, G., Wu, Y., Chiu, Y., Chen, W., Liao, J., Hsu, H., Chao, T., Hung, S., & Mao, F. C. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00427.x · Cited by 113
Longato, L., Tong, M., Wands, J. R., & de la Monte, S. M. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00934.x · Cited by 116
Influence of mTOR in energy and metabolic homeostasis
Haissaguerre, M., Saucisse, N., & Cota, D. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.015 · Cited by 128
Mollaei, M., Hassan, Z. M., Khorshidi, F., & Langroudi, L. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101056 · Cited by 131
Kim, S. J., DeStefano, M. A., Oh, W. J., Wu, C.-C., Vega-Cotto, N. M., Finlan, M., Liu, D., Su, B., & Jacinto, E. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.029 · Cited by 108
“…elevated activation of the mTORC1/S6K pathway that can occur in the absence of TSC1/TSC2 elicits a negative feedback signal that hyperphosphorylates IRS-1 at Ser residues, thereby diminishing insulin signals (Harrington et al., 2004; Shah et al., 2004; Tremblay and Marette, 2001; Um et al., 2004).”
mTOR, cardiomyocytes and inflammation in cardiac hypertrophy
Xu, L., & Brink, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.003 · Cited by 119
“This loop normally stops signaling directly downstream of tyrosine kinase receptors and its inhibition by rapamycin results in an upregulation of PI3K-AKT signaling [131-133].”
BackgroundLipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy
Liu, K., Qiu, D., Liang, X., Huang, Y., Wang, Y., Jia, X., Li, K., Zhao, J., Du, C., Qiu, X., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1961072 · Cited by 119
“As the downstream signaling of MTORC1, RPS6KB1-RPS6 (ribosomal protein S6) signaling, but not EIF4EBP1 signaling, has been detected when LD accumulation is increased [7,8].”
BackgroundMolecular Mechanisms of Hypothalamic Insulin Resistance
Ono, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061317 · Cited by 115
“Systemic deletion of S6K protects mice from diet-induced obesity and insulin resistance [82].”
BackgroundThe Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
Cui, D., Qu, R., Liu, D., Xiong, X., Liang, T., & Zhao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775507 · Cited by 119
“First, S6K, a substrate of mTORC1, decreases the activity and protein levels of IRS1 by phosphorylating it (Harrington et al., 2004; Um et al., 2004; Shah et al., 2004).”
BackgroundFOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle
Southgate, R. J., Neill, B., Prelovsek, O., El-Osta, A., Kamei, Y., Miura, S., Ezaki, O., McLoughlin, T. J., Zhang, W., Unterman, T. G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702039200 · Cited by 105
RetractedUsing Drosophila to discover mechanisms underlying type 2 diabetes
Alfa, R. W., & Kim, S. K. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.023887 · Cited by 125
“The TORC1 effector S6K1 exerts negative feedback on IIS (Kockel et al., 2010) and loss of this effector is protective against HFD-induced insulin resistance in mice (Um et al., 2004).”
BackgroundThe Sam68 STAR RNA-Binding Protein Regulates mTOR Alternative Splicing during Adipogenesis
Huot, M., Vogel, G., Zabarauskas, A., Ngo, C. T.-A., Coulombe‐Huntington, J., Majewski, J., & Richard, S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.007 · Cited by 115
Liu, H.-Y., Hong, T., Wen, G.-B., Han, J., Zuo, D., Liu, Z., & Cao, W. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2009 · Cited by 115
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.004 · Cited by 123
“Ser-636 (h) ERK1/2 [51] Ser-636 (h) / Ser-639 (m) MTOR complex 1 S6 kinase 1 [52]”
Whey proteins and peptides in health-promoting functions – A review
Zhao, C., Chen, N., & Ashaolu, T. J. (2021) · International Dairy Journal · doi:10.1016/j.idairyj.2021.105269 · Cited by 119
Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle
Ham, D. J., Börsch, A., Chojnowska, K., Lin, S., Leuchtmann, A. B., Ham, A. S., Thürkauf, M., Delezie, J., Furrer, R., Bürri, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29714-6 · Cited by 123
Mori, S., Nada, S., Kimura, H., Tajima, S., Takahashi, Y., Kitamura, A., Oneyama, C., & Okada, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088891 · Cited by 105
“Activated S6K1 phosphorylates Grb10, which mediates negative-feedback regulation of growth-factor signaling [17].”
BackgroundInfluentialLeucine and Protein Metabolism in Obese Zucker Rats
She, P., Olson, K. C., Kadota, Y., Inukai, A., Shimomura, Y., Hoppel, C. L., Adams, S. H., Kawamata, Y., Matsumoto, H., Sakai, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059443 · Cited by 108
“, [40], could be posited to be elevated on one hand when muscle mass accretion in obese Zucker rats is decreased on the other.”
BackgroundKang, S., Chemaly, E. R., Hajjar, R. J., & Lebeche, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200022 · Cited by 108
PDK1: The Major Transducer of PI 3-Kinase Actions
Bayascas, J. R. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_43 · Cited by 130
Shan, T., Xiong, Y., Zhang, P., Li, Z., Jiang, Q., Bi, P., Yue, F., Yang, G., Wang, Y., Liu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms12205 · Cited by 113
The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation
Bjedov, I., & Rallis, C. (2020) · Genes · doi:10.3390/genes11091043 · Cited by 104
“Interestingly, S6K1 null mice are resistant to diet induced obesity [134], and their transcriptomic changes resemble transcriptome under caloric restriction and AMPK activation by AICAR [129].”
BackgroundPardo, V., González‐Rodríguez, Á., Muntané, J., Kozma, S. C., & Valverde, Á. M. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.03.029 · Cited by 113
Self-citationBlättler, S. M., Cunningham, J. T., Verdeguer, F., Chim, H., Haas, W., Liu, H., Romanino, K., Rüegg, M. A., Gygi, S. P., Shi, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.008 · Cited by 105
“…to what would be predicted based on the mTOR-activated S6K negative feedback on insulin signaling (Haruta et al., 2000; Sarbassov et al., 2005; Um et al., 2004), a percentage of patients treated with mTOR inhibitors develop a variety of diabetic-like symptoms, including glucose intolerance,…”
BackgroundResultCerovac, V., Garcia, J. L. M., Rubinfeld, H., Buchfelder, M., Losa, M., Florio, T., Páez-Pereda, M., Stalla, G. K., & Theodoropoulou, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2951 · Cited by 115
Aguilar, V., & Fajas, L. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000089 · Cited by 100
Antonova, Y., Arik, A. J., Moore, W., Riehle, M. A., & Brown, M. R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384749-2.10002-0 · Cited by 122
Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes
Yuan, T., Rafizadeh, S., Gorrepati, K. D. D., Lupše, B., Oberholzer, J., Maedler, K., & Ardestani, A. D. (2016) · Diabetologia · doi:10.1007/s00125-016-4188-9 · Cited by 114
Insulin Resistance in the Defense against Obesity
Saltiel, A. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.001 · Cited by 116
Caccamo, A., Branca, C., Talboom, J. S., Shaw, D. M., Turner, D., Ma, L., Messina, A., Huang, Z., Wu, J., & Oddo, S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2781-15.2015 · Cited by 105
“As mentioned above, S6K1 plays a key role in metabolic function and insulin resistance (Um et al., 2004).”
BackgroundInfluentialShan, T., Zhang, P., Jiang, Q., Xiong, Y., Wang, Y., & Kuang, S. (2016) · Diabetologia · doi:10.1007/s00125-016-4006-4 · Cited by 104
“Mice lacking ribosomal S6 kinase 1 (S6K1), a key downstream target of mTORC1, have relatively lower fat mass and higher energy expenditure [13, 25].”
BackgroundInfluentialMicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma
Sun, J., Chen, Z., Tan, X., Zhou, F., Tan, F., Gao, Y., Sun, N., Xu, X., Shao, K., & He, J. (2013) · Medical Oncology · doi:10.1007/s12032-012-0411-9 · Cited by 105
Shin, S., Wolgamott, L., Tcherkezian, J., Vallabhapurapu, S., Yu, Y., Roux, P. P., & Yoon, S.-O. (2013) · Oncogene · doi:10.1038/onc.2013.113 · Cited by 110
Antagonistic control of muscle cell size by AMPK and mTORC1
Mounier, R., Lantier, L., Leclerc, J., Sotiropoulos, A., Foretz, M., & Viollet, B. (2011) · Cell Cycle · doi:10.4161/cc.10.16.17102 · Cited by 100
Liu, Y., Tanabe, K., Baronnier, D., Patel, S., Woodgett, J. R., CRAS-MÉNEUR, C. M. H., & Permutt, M. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1882-x · Cited by 117
“In vitro studies with rapamycin showed inhibition of proliferation [11], and in vivo knockout of S6k1 (also known as S6k) resulted in reduced beta cell mass and diabetes [38].”
Of bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat
Shavlakadze, T., & Grounds, M. (2006) · BioEssays · doi:10.1002/bies.20479 · Cited by 103
“Some of the molecules that affect both myogenesis and adipogenesis are Akt,((88,89)) S6K1,((90)) myostatin,((91)) ADAM12((92)) and DLK1.”
BackgroundMethodInfluentialNairizi, A., She, P., Vary, T. C., & Lynch, C. J. (2009) · Journal of Nutrition · doi:10.3945/jn.108.100081 · Cited by 108
Hasan, M., Gonugunta, V. K., Dobbs, N., Ali, A., Palchik, G., Calvaruso, M. A., DeBerardinis, R. J., & Yan, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611113114 · Cited by 98
“Trex1 mice also display reduced body size and weight that resembles reduced mTORC1 function as in S6K or Raptor conditional knockout mice (8, 9) (Fig.”
BackgroundTargeting the CNS to treat type 2 diabetes
Sandoval, D. A., Obici, S., & Seeley, R. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2874 · Cited by 115
Mammalian life-span determinant p66 shcA mediates obesity-induced insulin resistance
Ranieri, S. C., Fusco, S., Panieri, E., Labate, V., Mele, M., Tesori, V., Ferrara, A. M., Maulucci, G., De Spirito, M., Martorana, G. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008647107 · Cited by 101
“More importantly, constitutive activation of the S6 kinase-S6 cascade in the visceral white fat of p66WT obese mice (6) was nearly abolished in weightmatched obese animals lacking p66shc (Fig.”
Backgroundp70 Ribosomal protein S6 kinase ( Rps6kb1 ): an update
Bahrami-B, F., Ataie-Kachoie, P., Pourgholami, M. H., & Morris, D. L. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202560 · Cited by 96
Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 106
The RasGrf family of mammalian guanine nucleotide exchange factors
Fernández-Medarde, A., & Santos, E. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.11.001 · Cited by 101
Cleasby, M. E., Reinten, T. A., Cooney, G. J., James, D. E., & Kraegen, E. W. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0154 · Cited by 100
mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK
Melemedjian, O. K., Khoutorsky, A., Sorge, R. E., Yan, J., Asiedu, M. N., Valdez, A., Ghosh, S., Dussor, G. O., Mogil, J. S., Sonenberg, N., et al. (2013) · Pain · doi:10.1016/j.pain.2013.03.021 · Cited by 106
“IRS-1 S636/639 residues are phosphorylated by S6K [35,43], while the S789 site is phosphorylated by AMPK [42].”
BackgroundClk2 and B56β mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt
Rodgers, J. T., Vogel, R. O., & Puigserver, P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.007 · Cited by 99
Mieulet, V., Roceri, M., Espeillac, C., Sotiropoulos, A., Ohanna, M., Oorschot, V., Klumperman, J., Sandri, M., & Pende, M. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00499.2006 · Cited by 99
Mild suppression of hyperinsulinemia to treat obesity and insulin resistance
Page, M. M., & Johnson, J. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.03.018 · Cited by 99
Physical inactivity, insulin resistance, and the oxidative-inflammatory loop
Gratas-Delamarche, A., Derbré, F., Vincent, S., & Cillard, J. (2014) · Free Radical Research · doi:10.3109/10715762.2013.847528 · Cited by 99
Homeostatic regulation of protein intake: in search of a mechanism
Morrison, C. D., Reed, S. D., & Henagan, T. M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00609.2011 · Cited by 99
TOR and ageing: a complex pathway for a complex process
McCormick, M. A., Tsai, S.-Y., & Kennedy, B. K. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0198 · Cited by 96
Divergent Roles for IRS-1 and IRS-2 in Breast Cancer Metastasis
Gibson, S. L., Ma, Z., & Shaw, L. M. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3987 · Cited by 107
Metabolic alterations in renal cell carcinoma
Massari, F., Ciccarese, C., Santoni, M., Brunelli, M., Piva, F., Modena, A., Bimbatti, D., Fantinel, E., Santini, D., Cheng, L., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.07.002 · Cited by 108
“mTOR controls adipogenesis, through mechanisms involving the nuclear receptor PPARc and signaling via S6K1 [92,93], inhibiting lipolysis and therefore supporting adipocytes clustering and lipid accumulation.”
BackgroundThe integral role of mTOR in lipid metabolism
Soliman, G. A. (2011) · Cell Cycle · doi:10.4161/cc.10.6.14930 · Cited by 99
“Using human BJAB B-lymphoma cell lines and murine CTLL-2 T lymphocytes, Peng et al. (2002) reported that rapamycin treatment (12 and 24 hours) increases VLACD (Very Long Acetyl CoA Dehydrogenase) enzyme gene expression, as well as CAT expression, indicating that inhibition of mTOR leads to accelerated β-oxidation and…”
BackgroundFriedman, J. E., Kirwan, J. P., Jing, M., Presley, L., & Catalano, P. M. (2008) · Diabetes · doi:10.2337/db07-1356 · Cited by 98
“Both IR and IRS-1 serine phosphorylation have been suggested as major mechanisms for insulin resistance in mouse models of obesity and GDM (31,34,35) and in skeletal muscle of obese humans (36).”
BackgroundIGF signaling defects as causes of growth failure and IUGR
Klammt, J., Pfäffle, R. W., Werner, H., & Kieß, W. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.03.003 · Cited by 113
Gastric Mammalian Target of Rapamycin Signaling Regulates Ghrelin Production and Food Intake
Xu, G., Li, Y., An, W., Li, S., Guan, Y., Wang, N., Tang, C., Wang, X., Zhu, Y., Li, X., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0372 · Cited by 97
“induced obesity and improves insulin sensitivity in mice (7).”
BackgroundHaeri, A., Osouli, M., Bayat, F., Alavi, S., & Dadashzadeh, S. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1408123 · Cited by 102
Yang, Z., & Ming, X. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01038.x · Cited by 97
“the Akt) resulting from hyperactive S6K1-mediated phosphorylation of insulin receptor substrate 1 (IRS-1) at serine residues which promotes IRS1 degradation (18) (Fig.”
BackgroundInfluentialCell senescence: Hypertrophic arrest beyond the restriction point
Blagosklonny, M. V. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20750 · Cited by 93
“In contrast, activation of downstream pathways by c-myc, E2F, CDK2, viral oncoproteins (e.g., E1A, T-antigen) may execute cell-cycle progression (Hanahan and Weinberg, 2000; Sherr, 2004; Vogelstein and Kinzler, 2004).”
BackgroundThe Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
Soliman, G. (2013) · Nutrients · doi:10.3390/nu5062231 · Cited by 92
“However, the results vary across the cancer spectrum, attributable, in part, to the discovery of rapamycin-resistant functions of mTOR, the unfolding intricacies of mTOR complexes, and negative [39] and positive feedbacks [196] on insulin signaling pathway, as well as cross talk with oncogenic and tumor suppressors pa…”
BackgroundVergès, B. L., Walter, T., & Cariou, B. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0586 · Cited by 102
Tao, R., Xiong, X., Liangpunsakul, S., & Dong, X. C. (2015) · Diabetes · doi:10.2337/db14-0539 · Cited by 96
“Knockdown of Raptor or S6K1 increased phosphorylation of only Akt-S473 in WT mouse hepatocytes, which is consistent with previous reports (18,44); however, it did not affect Akt in Sesn3-LKO hepatocytes (Fig.”
ResultBeyond controlling cell size: functional analyses of S6K in tumorigenesis
Wu, X., Xie, W., Xie, W., Wei, W., & Guo, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05081-4 · Cited by 98
“For the insulin response, high-fat diet-mediated excess nutrients might potentiate mTORC1-S6K activation, leading to IRS1 phosphorylation and degradation, thus desensitizing insulin signaling [38].”
BackgroundInfluentialObesity resistance and increased hepatic expression of catabolism‐related mRNAs in Cnot3+/− mice
Morita, M., Oike, Y., Nagashima, T., Kadomatsu, T., Tabata, M., Suzuki, T., Nakamura, T., Yoshida, N., Okada, M., & Yamamoto, T. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.320 · Cited by 110
“To date, various types of lean mice have been generated by disrupting genes such as those coding for regulators of gene expression, which include transcription factors C/EBPb (Tanaka et al, 1997; Liu et al, 1999) and PGC-1a (Lin et al, 2004) and translation regulators 4E-BP1 (Tsukiyama-Kohara et al, 2001) and S6K1 (Um…”
BackgroundPersonalized phosphoproteomics identifies functional signaling
Needham, E. J., Hingst, J. R., Parker, B. L., Morrison, K. R., Yang, G., Onslev, J., Kristensen, J. M., Højlund, K., Ling, N. X. Y., Oakhill, J. S., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01099-9 · Cited by 98
Inhibition of the mTOR pathway: A possible protective role in coronary artery disease
Tarantino, G., & Capone, D. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.770333 · Cited by 97
Chamcheu, J. C., Adhami, V. M., Esnault, S. J., Sechi, M., Siddiqui, I. A., Satyshur, K. A., Syed, D. N., Dodwad, S.-J. M., Chaves-Rodriquez, M.-I., Longley, B. J., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6769 · Cited by 103
“This resistance has been partially ascribed to a feedback loop that triggers Akt activation via p70S6K inhibition (33, 37, 44).”
mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics
Zhang, H., Xiao, X., Pan, Z., & Dokudovskaya, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02493-4 · Cited by 123
“342 This transition is regulated by mTORC1 inhibition, enabling the degradation of cellular components to fuel gluconeogenesis.”
Morris, D. L., Cho, K. W., Zhou, Y., & Rui, L. (2009) · Diabetes · doi:10.2337/db08-1388 · Cited by 93
Gassaway, B. M., Petersen, M. C., Surovtseva, Y. V., Barber, K. W., Sheetz, J. B., Aerni, H. R., Merkel, J. S., Samuel, V. T., Shulman, G. I., & Rinehart, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804379115 · Cited by 85
“Although several studies have implicated the canonical p70S6K substrate IRS1 S302 as a mediator of insulin resistance [reviewed by Copps and White (54)] and have suggested that reduced phosphorylation at this site is responsible for protection against lipid- and ageinduced insulin resistance in p70S6K-null mice (55),…”
BackgroundImpaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle
Vandanmagsar, B., Warfel, J. D., Wicks, S. E., Ghosh, S., Salbaum, J. M., Burk, D., Dubuisson, O. S., Mendoza, T. M., Zhang, J., Noland, R. C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.057 · Cited by 92
“Alternatively,whenFAwaspresent, FGF21wasable to reducephosphorylation of mTor (Ser2448), p70S6K, IRS1 (Ser636/639), and Akt (Ser473) (Figure 3E).”
Hwang, S., Jeong, Y., Li, X., Kim, Y. D., Lu, Y., Chang, Y., Lee, I., & Chang, H. W. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12124 · Cited by 90
Akt and PTEN: β-cell mass and pancreas plasticity
Elghazi, L., & Bernal‐Mizrachi, E. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.03.002 · Cited by 99
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100461 · Cited by 88
“In turn, overactivated mTOR causes insulin resistance [30-42].”
BackgroundThe mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 98
Al‐Ali, H., Ding, Y., Slepak, T. I., Wu, W., Sun, Y., Martinez‐Ondaro, Y., Xu, X., Lemmon, V., & Bixby, J. L. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0931-17.2017 · Cited by 97
“In dividing cells, S6K1 acts as a negative feedback regulator of the PI3K/mTOR pathway, such that inhibition of S6K1 leads to induction of PI3K signaling and subsequent activation of mTOR (Pende et al., 2004; Um et al., 2004; Magnuson et al., 2012).”
BackgroundRoles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1
Hiratani, K., Haruta, T., Tani, A., Kawahara, J., Usui, I., & Kobayashi, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.152 · Cited by 101
PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling
Vinciguerra, M., & Foti, M. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600711359 · Cited by 89
“, 2002), S6K1 (Manning, 2004; Um et al., 2004) and ERK1/2 (De Fea & Roth, 1997) target primarily the insulin receptor and its substrates IRS1 and IRS2 by phosphorylating these proteins on negative regulatory serine or threonine residues.”
BackgroundInfluentialObestatin as a regulator of adipocyte metabolism and adipogenesis
Gurriarán‐Rodríguez, U., Al–Massadi, O., Roca-Rivada, A., Crujeiras, A. B., Gallego, R., Pardo, M., Seoane, L. M., Pazos, Y., Casanueva, F. F., & Camiña, J. P. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01192.x · Cited by 96
“Loss of mTORC1/S6K1 activity correlates with a decrease in fat accumulation, suggesting that the mTOR pathway is required for fat accumulation [45, 46].”
BackgroundmTORC1 signaling and regulation of pancreatic β-cell mass
Blandino-Rosano, M., Chen, A. Y., Scheys, J. O., Alejandro, E. U., Gould, A. P., Taranukha, T., Elghazi, L., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2012) · Cell Cycle · doi:10.4161/cc.20036 · Cited by 98
“mTORC1 controls growth (cell size), proliferation (cell number) and metabolism directly, by modulating eukaryotic initiation factor 4E-binding proteins (4E-BP 1, 2 and 3) and ribosomal protein S6 kinases (S6K 1 and 2), and indirectly, by attenuating AKT signaling via an mTORC1/ S6K-mediated negative feedback loop.(1-1…”
BackgroundInfluentialSuppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis
Ma, Z., Gibson, S. L., Byrne, M. A., Zhang, J., White, M. F., & Shaw, L. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01032-06 · Cited by 97
“sensitivity and glucose homeostasis (1, 39, 74).”
Leucine in Obesity: Therapeutic Prospects
Yao, K., Duan, Y., Li, F., Tan, B., Hou, Y., Wu, G., & Yin, Y. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.004 · Cited by 100
Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase
Yoneyama, Y., Inamitsu, T., Chida, K., Iemura, S.-I., Natsume, T., Maeda, T., Hakuno, F., & Takahashi, S.-I. (2018) · iScience · doi:10.1016/j.isci.2018.06.006 · Cited by 85
“Therefore, S6K1 is unlikely to trigger IRS-1 degradation under physiological conditions like persistent insulin/IGF stimuli, although S6K1 mediates a negative feedback in ways other than IRS-1 degradation as reportedly shown in S6K1 knockout mice (Um et al., 2004).”
BackgroundJin, G., Lee, S.-W., Zhang, X., Cai, Z., Gao, Y., Chou, P.-C., Rezaeian, A. H., Han, F., Wang, C.-Y., Yao, J.-C., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.010 · Cited by 87
“Previous studies demonstrate that both mTORC1 and its downstream kinase S6K1 induce negative feedback regulation of growth-factor-dependent mTORC1 signaling through directly phosphorylating IRS1 (Hartman et al., 2009; Tzatsos and Kandror, 2006; Um et al., 2004).”
Danielsson, A., Öst, A., Nystrom, F. H., & Strålfors, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500230200 · Cited by 89
SH3BP4 Is a Negative Regulator of Amino Acid-Rag GTPase-mTORC1 Signaling
Kim, Y.-M., Stone, M., Hwang, T. H., Kim, Y.-G., Dunlevy, J. R., Griffin, T. J., & Kim, D.-H. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.007 · Cited by 88
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.